Petros Pharmaceuticals, Inc. - PTPI
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | History | New | 563,594 | 38 | 0.0% | — | 1 | +563,594 | New | Q1 2025 | May 19, 2025 |
| UBS Group AG | History | Added to | 119,072 | 8 | 0.0% | 0.0% | 2 | +106,080 | 816.5% | Q1 2025 | May 13, 2025 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Added to | 108,180 | 7 | 0.0% | 0.0% | 3 | +71,996 | 198.97% | Q1 2025 | May 13, 2025 |
| XTX Topco Ltd | History | New | 90,905 | 6 | 0.0% | — | 4 | +90,905 | New | Q1 2025 | May 08, 2025 |
| VANGUARD GROUP INC | History | No change | 31,811 | 2 | 0.0% | 0.0% | 5 | 0 | 0.0% | Q1 2025 | May 09, 2025 |
| BlackRock, Inc. | History | No change | 16,128 | 1 | 0.0% | 0.0% | 6 | 0 | 0.0% | Q1 2025 | May 02, 2025 |
| MORGAN STANLEY | History | Added to | 704 | 0 | — | — | — | +685 | 3605.26% | Q1 2025 | May 15, 2025 |
| SBI Securities Co., Ltd. | History | New | 320 | 0 | — | — | — | +320 | New | Q1 2025 | May 02, 2025 |
| Tower Research Capital LLC (TRC) | History | New | 11 | 0 | — | — | — | +11 | New | Q1 2025 | May 15, 2025 |
| BANK OF AMERICA CORP /DE/ | History | Added to | 79 | 0 | — | — | — | +4 | 5.33% | Q1 2025 | May 15, 2025 |
| NATIONAL BANK OF CANADA /FI/ | History | No change | 200 | 0 | — | — | — | 0 | 0.0% | Q1 2025 | May 12, 2025 |
| GROUP ONE TRADING LLC | History | No change | 79 | 0 | — | — | — | 0 | 0.0% | Q1 2025 | May 14, 2025 |
| OSAIC HOLDINGS, INC. | History | No change | 200 | 0 | — | — | — | 0 | 0.0% | Q1 2025 | May 12, 2025 |